Literature DB >> 27188553

In Vitro and In Vivo Blood-Brain Barrier Models to Study West Nile Virus Pathogenesis.

Mukesh Kumar1,2, Vivek R Nerurkar3,4.   

Abstract

The blood-brain barrier (BBB), a specialized interface between the peripheral blood circulation and the central nervous system, specifically regulates molecular and cellular flux between the two. It plays a critical role in the maintenance of brain hemostasis. The BBB restricts the entry of pathogens into the brain, and thus its permeability is a critical factor that determines their central effects. Once the permeability of BBB is compromised, it has serious implications in the etiology of many brain pathologies including West Nile virus (WNV) disease. In this chapter, we describe protocols for preparation, maintenance, infection and permeability measurement of monolayer and bilayer in vitro BBB models to study WNV pathogenesis. We also describe Evans blue dye assay, a well-established method to test vascular permeability in vivo after WNV infection.

Entities:  

Keywords:  Blood–brain barrier; Transmigration; West Nile virus encephalitis

Mesh:

Year:  2016        PMID: 27188553      PMCID: PMC5502104          DOI: 10.1007/978-1-4939-3670-0_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

1.  Dengue hemorrhagic fever-associated immunomediators induced via maturation of dengue virus nonstructural 4B protein in monocytes modulate endothelial cell adhesion molecules and human microvascular endothelial cells permeability.

Authors:  James F Kelley; Pakieli H Kaufusi; Vivek R Nerurkar
Journal:  Virology       Date:  2011-11-29       Impact factor: 3.616

Review 2.  Blood-brain barrier: structural components and function under physiologic and pathologic conditions.

Authors:  Yuri Persidsky; Servio H Ramirez; James Haorah; Georgette D Kanmogne
Journal:  J Neuroimmune Pharmacol       Date:  2006-07-06       Impact factor: 4.147

3.  West Nile virus-induced disruption of the blood-brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases.

Authors:  Kelsey Roe; Mukesh Kumar; Stephanie Lum; Beverly Orillo; Vivek R Nerurkar; Saguna Verma
Journal:  J Gen Virol       Date:  2012-03-07       Impact factor: 3.891

4.  Resurgence of West Nile neurologic disease in the United States in 2012: what happened? What needs to be done?

Authors:  David W C Beasley; Alan D T Barrett; Robert B Tesh
Journal:  Antiviral Res       Date:  2013-04-26       Impact factor: 5.970

5.  Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis.

Authors:  Tian Wang; Terrence Town; Lena Alexopoulou; John F Anderson; Erol Fikrig; Richard A Flavell
Journal:  Nat Med       Date:  2004-11-21       Impact factor: 53.440

6.  Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor.

Authors:  Saguna Verma; Mukesh Kumar; Ulziijargal Gurjav; Stephanie Lum; Vivek R Nerurkar
Journal:  Virology       Date:  2009-11-18       Impact factor: 3.616

7.  West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier.

Authors:  Saguna Verma; Yeung Lo; Moti Chapagain; Stephanie Lum; Mukesh Kumar; Ulziijargal Gurjav; Haiyan Luo; Austin Nakatsuka; Vivek R Nerurkar
Journal:  Virology       Date:  2009-01-10       Impact factor: 3.616

8.  Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain.

Authors:  Penghua Wang; Jianfeng Dai; Fengwei Bai; Kok-Fai Kong; Susan J Wong; Ruth R Montgomery; Joseph A Madri; Erol Fikrig
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

9.  Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion.

Authors:  Alvaro Arjona; Harald G Foellmer; Terrence Town; Lin Leng; Courtney McDonald; Tian Wang; Susan J Wong; Ruth R Montgomery; Erol Fikrig; Richard Bucala
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

10.  Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection.

Authors:  William G Glass; Jean K Lim; Rushina Cholera; Alexander G Pletnev; Ji-Liang Gao; Philip M Murphy
Journal:  J Exp Med       Date:  2005-10-17       Impact factor: 14.307

View more
  1 in total

1.  Zika virus crosses an in vitro human blood brain barrier model.

Authors:  Judie B Alimonti; Maria Ribecco-Lutkiewicz; Caroline Sodja; Anna Jezierski; Danica B Stanimirovic; Qing Liu; Arsalan S Haqqani; Wayne Conlan; Mahmud Bani-Yaghoub
Journal:  Fluids Barriers CNS       Date:  2018-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.